The Institute of Medical Virology (IMV) is part of both the medical and science faculties at the University of Zurich. Our institute comprises diagnostic and research laboratories and educates medical and biology students.
We are seeking a highly motivated Postdoc with a robust computation and quantitative statistics background to contribute to a cutting-edge project at the intersection of bioinformatics, virology, and HIV immunology.
You will contribute to an interdisciplinary and translational HIV vaccine research project that involves intensive experimental work and data analyses, fostered by close collaborations between the group of Alexandra Trkola at the Institute of Medical Virology, University of Zurich, the groups of Roger Kouyos and Huldrych Günthard at the Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and international partners.
Your responsibilities
Analyzing complex immunological and clinical datasets from the Swiss HIV Cohort Study (www.shcs.ch), the Zurich Primary HIV Study and an upcoming HIV vaccine trial scheduled for 2024. The primary goal of the three-year project is to identify the determinants that influence the induction of broadly neutralizing antibodies against HIV by studying the immune responses pre- and post-vaccination.
Your profile
Given the complexity of the data, the successful applicant must employ mathematical and bioinformatics approaches beyond conventional statistics:
- Possess robust quantitative/computational skills
- Ph.D. in a relevant field, such as Bioinformatics, Bio-Statistics, Bio-Mathematics, or Life Sciences with a substantial quantitative or computational component.
- Ability to work constructively and effectively, both independently and as part of a multidisciplinary research team.
- Very good command of English
What we offer
- A dynamic and interdisciplinary research environment with connections to both clinical practice and fundamental science.
- A stimulating work environment connecting researchers in HIV virology and vaccinology, clinical and theoretical infectious diseases.
- Access to unique immunological and clinical data, providing the opportunity to shape subsequent experimental analyses on pivotal questions in HIV vaccinology.
Place of work
Start of employment
Employment start date from April 2024 onwards or to be mutually agreed. The position is fixed-term.
Interested applicants are invited to submit a cover letter, a comprehensive CV, a list of publications, and contact details for two or three academic references.
Further information
Prof. Dr. rer nat Alexandra Trkola
Prof. Dr. Roger Kouyos